Fox, in a year or two, dxb will either be worth a buck or zero....

Fox, in a year or two, dxb will either be worth a buck or zero. All of us on here, both realists and dreamers, would hands down prefer the former.

As for the free options to westar, having them issued at say the cr issue price of 12c would be like bashing a shareholder to death, reviving them with a defribilator, then running them over with a stretch limo while the westar brokers are on their way to spend their juicy commission at Perth casino. At least at 25c & 50c the dilution effect is somewhat more palatable V current 11c share price.

In % terms, they are essentially getting ~ 1.5% of the company for free. Risk = Zero

Either way, those options are free...no skin in the game unlike you and I and all those on this board.

Personally I am backing the stock purely for the science and that's what's keeping me involved. The CEO and all the rest of the key decision makers are undoubtedly qualified and specialists in their field, however the undeniable truth is that DXB has been a perennial underperformer.

It's a great story which has not been able to reflect its true potential in the share price. The FSGS & DN markets are well over US$2 billion pa in the US and DXB has arguably a superior drug candidate than anything else in the market, with an IP that blocks other competitors from entering their space. Yet the co. is valued at <$20M with half its value in cash.

Sleeping giant or write off. Only time will tell. Let's hope the science can pull it off since I believe that's all they've got going for them.